Filing Details

Accession Number:
0001104659-19-016423
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-21 07:05:28
Reporting Period:
2019-03-19
Accepted Time:
2019-03-21 07:05:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658379 Mark Coleman C/O Axsome Therapeutics, Inc
25 Broadway, 9Th Floor
New York NY 10004
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-19 5,100 $12.18 5,100 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 647,998 Direct
Footnotes
  1. The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $12.09 to $12.53, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4.
  2. Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.
  3. Represents additional shares held directly by the reporting person prior to March 19, 2019.